I'm near-certain that this study has already been written up in the sub, but I can't find it, so it's here until I do.
Results All subjects in the Ivermectin-Doxycycline group (group A) reached a negative PCR for SARS-CoV-2, at a mean of 8.93 days, and all reached symptomatic recovery, at a mean of 5.93 days, with 55.10% symptom-free by the 5th day. In the Hydroxychloroquine-Azithromcyin group (group B), 96.36% reached a negative PCR at a mean of 6.99 days and were symptoms-free at 9.33 days.
[-] TrumpLyftAlles | 2 points | Aug 17 2020 06:39:55
I'm near-certain that this study has already been written up in the sub, but I can't find it, so it's here until I do.
Results All subjects in the Ivermectin-Doxycycline group (group A) reached a negative PCR for SARS-CoV-2, at a mean of 8.93 days, and all reached symptomatic recovery, at a mean of 5.93 days, with 55.10% symptom-free by the 5th day. In the Hydroxychloroquine-Azithromcyin group (group B), 96.36% reached a negative PCR at a mean of 6.99 days and were symptoms-free at 9.33 days.
permalink